Zapanta JBJ, Gorospe CV. Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer after Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report. Asian Pac J Cancer Care [Internet]. 2025 Jul. 14 [cited 2026 May 29];10(3):989-92. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/1534